04/29/2024 3:49 PM | Madrigal Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024 7:50 PM | FRIEDMAN PAUL A (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 7:53 PM | Madrigal Pharmaceuticals (Issuer) Taub Rebecca (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 7:50 PM | FRIEDMAN PAUL A (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 7:50 PM | Madrigal Pharmaceuticals (Issuer) Taub Rebecca (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:41 PM | Daly James M (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:44 PM | BATE KENNETH (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/03/2024 7:47 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 3:22 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024 3:21 PM | BAKER BROS. ADVISORS LP (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 3:28 PM | BAKER BROS. ADVISORS LP (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/21/2024 3:30 PM | Dier Mardi (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/20/2024 3:11 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:10 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:01 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 5:32 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 1:50 PM | ARMISTICE CAPITAL, LLC (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 8:21 AM | Avoro Capital Advisors LLC (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024 4:55 PM | JANUS HENDERSON GROUP PLC (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024 5:04 PM | Huntsman Carole (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 4:50 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 4:54 PM | Madrigal Pharmaceuticals (Issuer) Taub Rebecca (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 10:13 AM | Madrigal Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 12:52 PM | Lynch Brian Joseph (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 12:39 PM | Howarth Alex G. (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 12:45 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 12:46 PM | Madrigal Pharmaceuticals (Issuer) Taub Rebecca (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 12:47 PM | FRIEDMAN PAUL A (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 12:45 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 3:30 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 5:09 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 5:10 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:30 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:25 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 3:30 PM | Lynch Brian Joseph (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 3:30 PM | Lynch Brian Joseph (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:02 PM | Huntsman Carole (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 5:14 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 5:15 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:24 PM | BAKER BROS. ADVISORS LP (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
11/15/2023 4:12 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:13 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 3:39 PM | Madrigal Pharmaceuticals (Subject) PAULSON & CO. INC. (Filed by)
| Form SC 13G | |
11/06/2023 7:31 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 5:10 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023 12:05 PM | JANUS HENDERSON GROUP PLC (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/05/2023 3:36 PM | BAKER BROS. ADVISORS LP (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/05/2023 3:27 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:15 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 4:10 PM | Madrigal Pharmaceuticals (Filer)
| Form 424B5 | |
09/28/2023 3:01 PM | Madrigal Pharmaceuticals (Filer)
| Form 424B5 | |
09/25/2023 3:02 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/14/2023 3:31 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 3:35 PM | Madrigal Pharmaceuticals (Issuer) Sibold William John (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/13/2023 3:41 PM | Madrigal Pharmaceuticals (Issuer) Sibold William John (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 3:25 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 3:30 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:31 PM | Madrigal Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/08/2023 3:36 PM | JANUS HENDERSON GROUP PLC (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G | |
08/08/2023 4:16 PM | BAKER BROS. ADVISORS LP (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
08/08/2023 8:19 AM | Madrigal Pharmaceuticals (Filer)
| Form 424B3 | |
08/08/2023 7:00 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 5:50 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/17/2023 7:00 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2023 1:21 PM | Gollust Keith R (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023 7:00 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 6:58 PM | Gollust Keith R (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023 7:04 PM | Gollust Keith R (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023 5:46 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 5:47 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:10 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 5:17 AM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/20/2023 5:19 AM | Cheong Raymond (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/09/2023 8:02 AM | Madrigal Pharmaceuticals (Filer)
| Form 424B5 | |
05/09/2023 7:00 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2023 7:16 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2023 5:51 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |